Ardith Ambrose
Overview
Explore the profile of Ardith Ambrose including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pott H, Andrew M, Shaffelburg Z, Nichols M, Ye L, ElSherif M, et al.
Open Forum Infect Dis
. 2025 Feb;
12(2):ofaf058.
PMID: 39968306
Background: Oseltamivir is recommended for the treatment of adults hospitalized with influenza, but adherence is often suboptimal. This may be due to doubts about the reliability of the evidence supporting...
2.
Pott H, Andrew M, Shaffelburg Z, Nichols M, Ye L, ElSherif M, et al.
Vaccine
. 2023 Sep;
41(42):6359-6365.
PMID: 37696717
Background: Influenza vaccines prevent influenza-related morbidity and mortality; however, suboptimal vaccine effectiveness (VE) of non-adjuvanted trivalent inactivated influenza vaccine (naTIV) or quadrivalent formulations in older adults prompted the use of...
3.
ElSherif M, Andrew M, Ye L, Ambrose A, Boivin G, Bowie W, et al.
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad315.
PMID: 37441353
Background: Respiratory syncytial virus (RSV) disease in older adults is undercharacterized. To help inform future immunization policies, this study aimed to describe the disease burden in Canadian adults aged ≥50...
4.
Mulpuru S, Andrew M, Ye L, Hatchette T, Leblanc J, El-Sherif M, et al.
Influenza Other Respir Viruses
. 2022 Sep;
16(6):1172-1182.
PMID: 36069141
Background: Seasonal respiratory viral infections are associated with exacerbations and morbidity among patients with COPD. The real-world clinical outcomes associated with seasonal viral infections are less well established among hospitalized...
5.
Andrew M, Godin J, Leblanc J, Boivin G, Valiquette L, McGeer A, et al.
Can Geriatr J
. 2022 Jun;
25(2):183-196.
PMID: 35747412
Background: We report characteristics and outcomes of adults admitted to Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network hospitals with COVID-19 in 2020. Methods: Patients with laboratory-confirmed COVID-19...
6.
LeBlanc J, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette T, et al.
Vaccine
. 2022 Mar;
40(18):2635-2646.
PMID: 35315326
Objective(s): In the context of age- and risk-based pneumococcal vaccine recommendations in Canada, this study presents updated data from active surveillance of pneumococcal community acquired pneumonia (pCAP) and invasive pneumococcal...
7.
Leblanc J, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette T, et al.
BMJ Open Respir Res
. 2020 Mar;
7(1).
PMID: 32188585
Background: In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is recommended in childhood, in individuals at high risk of invasive pneumococcal disease (IPD) and in healthy adults aged ≥65 years for...
8.
LeBlanc J, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette T, et al.
Vaccine
. 2019 Jul;
37(36):5466-5473.
PMID: 31345638
Background: The 13-valent pneumococcal conjugate vaccine (PCV13) was recently shown to be effective against PCV13-type invasive pneumococcal disease (IPD) and pneumococcal community acquired pneumonia (CAP) in healthy adults aged ≥65 ...
9.
Mulpuru S, Li L, Ye L, Hatchette T, Andrew M, Ambrose A, et al.
Chest
. 2019 Jan;
155(1):69-78.
PMID: 30616737
Background: The effectiveness of influenza vaccination in reducing influenza-related hospitalizations among patients with COPD is not well described, and influenza vaccination uptake remains suboptimal. Methods: Data were analyzed from a...
10.
Nichols M, Andrew M, Hatchette T, Ambrose A, Boivin G, Bowie W, et al.
Vaccine
. 2018 Mar;
36(16):2166-2175.
PMID: 29548608
Background: Ongoing assessment of influenza vaccine effectiveness (VE) is critical to inform public health policy. This study aimed to determine the VE of trivalent influenza vaccine (TIV) for preventing influenza-related...